Advertisement
Advertisement

AGL

AGL logo

agilon health, inc.

115.67
USD
Sponsored
+3.88
+3.47%
Jul 09, 15:59 UTC -4
Closed
exchange

After-Market

115.67

0.00
0.00%

AGL Earnings Reports

Positive Surprise Ratio

AGL beat 6 of 21 last estimates.

29%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.45B
/
-$0.17
Implied change from Q1 26 (Revenue/ EPS)
+2.34%
/
-109.44%
Implied change from Q2 25 (Revenue/ EPS)
+4.20%
/
-97.28%

agilon health, inc. earnings per share and revenue

On May 06, 2026, AGL reported earnings of 1.80 USD per share (EPS) for Q1 26, beating the estimate of 0.94 USD, resulting in a 89.87% surprise. Revenue reached 1.42 billion, compared to an expected 1.39 billion, with a 1.91% difference. The market reacted with a +117.81% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 1.45 billion USD, implying an decrease of -109.44% EPS, and increase of 2.34% in Revenue from the last quarter.
FAQ
For Q1 2026, agilon health, inc. reported EPS of $1.80, beating estimates by 89.87%, and revenue of $1.42B, 1.91% above expectations.
The stock price moved up 117.81%, changed from $27.85 before the earnings release to $60.66 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 11 analysts, agilon health, inc. is expected to report EPS of -$0.17 and revenue of $1.45B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement